proteanTecs
proteanTecs raises $51M Series D at $300M valuation
Quick Facts
proteanTecs: Series D Funding Round
proteanTecs has successfully raised $51M in Series D funding, reaching a valuation of $300M.
Company Overview
Semiconductor health and performance monitoring solutions for chip reliability
Funding Details
The Series D round was led by Mitsui & Co, with participation from Koch Disruptive Technologies.
Company Information
- Headquarters: Haifa, Israel
- Founded: 2017
- Employees: 120+
- Category: Semiconductor
Investment
proteanTecs plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Mitsui & Co: Verified investor in Series D
- Koch Disruptive Technologies: Verified investor in Series D
Key Investors
About the Author
Related Company Reports
Morse Micro raises $59M Series C at $350M valuation
Morse Micro raises $59M in Series C at $350M valuation. Fabless chipmaker specializing in Wi-Fi HaLow chips for IoT...
BrainChip Neural Raises $750M Series D to Transform Technology
BrainChip Neural secures $750M in Series D funding at $11.5B valuation to scale chip manufacturing, advance r&d for next-gen processors, and expand automotive partnerships.
Arago raises $26M Seed
Arago raises $26M in Seed. Photonic AI accelerators optimized for energy-efficient computing...